Biosimilar Newsletter Archive

1. 07.20.17 -- How Congress Can Help Biosimilars Succeed
   7/20/2017
   07/20/17 Biosimilar Development Newsletter
2. 07.13.17 -- How Retail Pharmacies Are Approaching Biosimilars
   7/13/2017
   07/13/17 Biosimilar Development Newsletter
3. 07.06.17 -- How Will Biosimilars Play Out In IDNs?
   7/6/2017
   07/06/17 Biosimilar Development Newsletter
4. 06.29.17 -- How Biosimilars Are Challenging The FDA Beyond The Science
   6/29/2017
   06/29/17 Biosimilar Development Newsletter
5. 06.27.17 -- Complying With The FDA While Modernizing Technology
   6/27/2017
   06/27/17 Biosimilar Development Newsletter
6. 06.22.17 -- Political Uncertainty Spurs Push For Accelerated Biosimilar Development
   6/22/2017
   06/22/17 Biosimilar Development Newsletter
7. 06.20.17 -- 5 Key Considerations For Expanding Biomanufacturing Capacity
   6/20/2017
   06/20/17 Biosimilar Development Newsletter
8. 06.15.17 -- Biosimilar Pharmacovigilance: What Progress Has Been Made?
   6/15/2017
   06/15/17 Biosimilar Development Newsletter
9. 06.08.17 -- Why Interchangeability Won't Be The "Silver Bullet" For Biosimilar Uptake
   6/8/2017
   06/08/17 Biosimilar Development Newsletter
10. 06.01.17 -- What To Think About A 70% Biosimilar Discount
    6/1/2017
    06/01/17 Biosimilar Development Newsletter